Search research articles
Contact Us
Filters
Showing results (51-60 of 189) with videos related to
Page
of 19
Sort By:
Oncology
|
January 1, 1987
Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma
F Boccardo, G Cerruti, R De Menech, et al.
Lymphology
|
September 26, 2018
Decreasing and preventing lymphatic-injury-related complications in patients undergoing venous surgery: A new diagnostic and therapeutic protocol
S Dessalvi, G Villa, C C Campisi, et al.
Minerva Medica
|
May 31, 1984
[Natural history and staging of brain metastases]
F Boccardo, G Comelli, R De Menech, et al.
Lymphology
|
June 9, 2009
Congenital lymphatic dysplasias: genetics review and resources for the lymphologist
C Bellini, M H Witte, C Campisi, et al.
Anticancer Research
|
November 29, 2005
4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro
F Boccardo, D Medicina, F Galmozzi, et al.
Tumori
|
August 31, 1994
R75251 in prostate cancer patients in progression after first-line hormonal treatment
F Boccardo, D Cannata, D Guarneri, et al.
Lymphology
|
December 8, 2007
Immunohistochemical studies in a hydroptic fetus with pulmonary lymphangiectasia and trisomy 21
M Rutigliani, F Boccardo, C Campisi, et al.
Cancer Treatment Reports
|
March 1, 1982
Phase II trial of thioproline in advanced epidermoid head and neck tumors
F Boccardo, A Barbieri, L Canobbio, et al.
Oncology
|
March 13, 2001
Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies
L Miglietta, C Marenghi, R Nizzo, et al.
Tumori
|
April 30, 1992
Phase II study with lonidamine in the treatment of hormone-refractory prostatic cancer patients
F Boccardo, D Guarneri, M Pace, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 189) with videos related to
Sort By:
Page
of 19
Oncology
|
January 1, 1987
Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma
F Boccardo, G Cerruti, R De Menech, et al.
Lymphology
|
September 26, 2018
Decreasing and preventing lymphatic-injury-related complications in patients undergoing venous surgery: A new diagnostic and therapeutic protocol
S Dessalvi, G Villa, C C Campisi, et al.
Minerva Medica
|
May 31, 1984
[Natural history and staging of brain metastases]
F Boccardo, G Comelli, R De Menech, et al.
Lymphology
|
June 9, 2009
Congenital lymphatic dysplasias: genetics review and resources for the lymphologist
C Bellini, M H Witte, C Campisi, et al.
Anticancer Research
|
November 29, 2005
4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro
F Boccardo, D Medicina, F Galmozzi, et al.
Tumori
|
August 31, 1994
R75251 in prostate cancer patients in progression after first-line hormonal treatment
F Boccardo, D Cannata, D Guarneri, et al.
Lymphology
|
December 8, 2007
Immunohistochemical studies in a hydroptic fetus with pulmonary lymphangiectasia and trisomy 21
M Rutigliani, F Boccardo, C Campisi, et al.
Cancer Treatment Reports
|
March 1, 1982
Phase II trial of thioproline in advanced epidermoid head and neck tumors
F Boccardo, A Barbieri, L Canobbio, et al.
Oncology
|
March 13, 2001
Paclitaxel by 72-hour continuous infusion followed by bolus intravenous ifosfamide or epirubicin: results of two phase I studies
L Miglietta, C Marenghi, R Nizzo, et al.
Tumori
|
April 30, 1992
Phase II study with lonidamine in the treatment of hormone-refractory prostatic cancer patients
F Boccardo, D Guarneri, M Pace, et al.
Page
of 19